Chemobrain: is systemic chemotherapy neurotoxic?

@article{Taillibert2007ChemobrainIS,
  title={Chemobrain: is systemic chemotherapy neurotoxic?},
  author={S. Taillibert and D. Voillery and C. Bernard-Marty},
  journal={Current Opinion in Oncology},
  year={2007},
  volume={19},
  pages={623–627}
}
  • S. Taillibert, D. Voillery, C. Bernard-Marty
  • Published 2007
  • Medicine
  • Current Opinion in Oncology
  • Purpose of review The existence of chemobrain has become almost universally accepted, although many details of the concept are controversial. Data about the different types of cognitive impairment and their duration are not always consistent in the literature. We still do not know which cytotoxic agents are responsible, which characteristics make patients vulnerable, and which biologic mechanisms are involved. Recent findings Through this review of the recent literature, we provide an… CONTINUE READING
    53 Citations
    Chemobrain: a translational challenge for neurotoxicology.
    • B. Weiss
    • Psychology, Medicine
    • Neurotoxicology
    • 2008
    • 56
    Brain damage from anticancer treatments in adults
    • 40
    Evaluation of multiple neurotoxic outcomes in cancer chemotherapy.
    • B. Weiss
    • Medicine
    • Advances in experimental medicine and biology
    • 2010
    • 15
    Why, After Chemotherapy, is it Necessary to Assess Memory Using Translational Testing?
    • S. Acevedo
    • Medicine
    • Breast cancer : basic and clinical research
    • 2012
    • 7
    • PDF
    Brain metastases and treatment: multiplying cognitive toxicities
    Integrating imaging findings in evaluating the post-chemotherapy brain
    • 48

    References

    SHOWING 1-9 OF 9 REFERENCES
    Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research.
    • J. Vardy, S. Rourke, I. Tannock
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2007
    • 238
    Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer.
    • V. Shilling, V. Jenkins
    • Medicine
    • European journal of oncology nursing : the official journal of European Oncology Nursing Society
    • 2007
    • 169
    Cognitive impairment associated with adjuvant therapy in breast cancer
    • 297
    Papers of particular interest, published within the annual period of review, have been highlighted as: of special interest of outstanding interest